Journal of General Virology, Vol 78, 825-835, Copyright © 1997 by Society for General Microbiology

ARTICLES

The non-immunosuppressive cyclosporin A analogue SDZ NIM 811 inhibits cyclophilin A incorporation into virions and virus replication in human immunodeficiency virus type 1-infected primary and growth-arrested T cells

E Mlynar, D Bevec, A Billich, B Rosenwirth and A Steinkasserer
Sandoz Research Institute, Vienna, Austria.

SDZ NIM 811 is a cyclosporin A (CsA) analogue that is completely devoid of immunosuppressive capacity but exhibits potent and selective anti- human immunodeficiency virus type 1 (HIV-1) activity. Binding to cyclophilin A, the intracellular receptor for cyclosporins, is a prerequisite for HIV-1 inhibition by cyclosporins. Cyclophilin A was demonstrated to bind to HIV-1 p24gag and this cyclophilin-Gag interaction leads to the incorporation of cyclophilin A into HIV-1 virions. SDZ NIM 811 inhibits this protein interaction, and this is likely to be the molecular basis for its antiviral activity. Here, we show that in activated primary T cells SDZ NIM 811 interferes with two stages of the virus replication cycle: (i) translocation of pre- integration complexes into the nucleus and (ii) production of infectious virus particles. SDZ NIM 811 not only inhibits translocation of HIV-1 pre-integration complexes in primary T cells, but also in a growth-arrested T cell line. In vivo, most T lymphocytes are quiescent, but serve nevertheless as a major and inducible HIV-1 reservoir in infected individuals. Significant amounts of cyclophilin A were found to be associated with virus particles propagated in primary T cells. SDZ NIM 811 caused a strong reduction in the amount of incorporated cyclophilin A, thereby reducing infectivity. Thus, cyclophilin A seems to be necessary for HIV-1 replication in primary T cells.

This article has been cited by other articles:

				R. G. Ptak, P. A. Gallay, D. Jochmans, A. P. Halestrap, U. T. Ruegg, L. A. Pallansch, M. D. Bobardt, M.-P. de Bethune, J. Neyts, E. De Clercq, et al. Inhibition of Human Immunodeficiency Virus Type 1 Replication in Human Cells by Debio-025, a Novel Cyclophilin Binding Agent Antimicrob. Agents Chemother., April 1, 2008; 52(4): 1302 - 1317. [Abstract] [Full Text] [PDF]

				M. Saini and M. J. Potash Novel Activities of Cyclophilin A and Cyclosporin A during HIV-1 Infection of Primary Lymphocytes and Macrophages J. Immunol., July 1, 2006; 177(1): 443 - 449. [Abstract] [Full Text] [PDF]

				U. Chatterji, M. D. Bobardt, R. Stanfield, R. G. Ptak, L. A. Pallansch, P. A. Ward, M. J. Jones, C. A. Stoddart, P. Scalfaro, J.-M. Dumont, et al. Naturally Occurring Capsid Substitutions Render HIV-1 Cyclophilin A Independent in Human Cells and TRIM-cyclophilin-resistant in Owl Monkey Cells J. Biol. Chem., December 2, 2005; 280(48): 40293 - 40300. [Abstract] [Full Text] [PDF]

				A. C. S. Saphire, M. D. Bobardt, and P. A. Gallay Cyclophilin A Plays Distinct Roles in Human Immunodeficiency Virus Type 1 Entry and Postentry Events, as Revealed by Spinoculation J. Virol., March 27, 2002; 76(9): 4671 - 4677. [Abstract] [Full Text] [PDF]

				A. C. S. Saphire, M. D. Bobardt, and P. A. Gallay trans-Complementation Rescue of Cyclophilin A-Deficient Viruses Reveals that the Requirement for Cyclophilin A in Human Immunodeficiency Virus Type 1 Replication Is Independent of Its Isomerase Activity J. Virol., March 1, 2002; 76(5): 2255 - 2262. [Abstract] [Full Text] [PDF]

				M. Srivastava, M. Cartas, T. A. Rizvi, S. P. Singh, D. Serio, V. S. Kalyanaraman, H. B. Pollard, and A. Srinivasan HIV-1 Gag shares a signature motif with annexin (Anx7), which is required for virus replication PNAS, March 16, 1999; 96(6): 2704 - 2709. [Abstract] [Full Text] [PDF]